{"id":"https://openalex.org/W2135103642","doi":"https://doi.org/10.1200/jco.2003.01.238","title":"Phase I and Pharmacokinetic Study of Two Different Schedules of Oxaliplatin, Irinotecan, Fluorouracil, and Leucovorin in Patients With Solid Tumors","display_name":"Phase I and Pharmacokinetic Study of Two Different Schedules of Oxaliplatin, Irinotecan, Fluorouracil, and Leucovorin in Patients With Solid Tumors","publication_year":2003,"publication_date":"2003-09-09","ids":{"openalex":"https://openalex.org/W2135103642","doi":"https://doi.org/10.1200/jco.2003.01.238","mag":"2135103642","pmid":"https://pubmed.ncbi.nlm.nih.gov/12963697"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2003.01.238","doi":"https://doi.org/10.1200/jco.2003.01.238","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2003.01.238","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008665323","display_name":"Matthew Philip Goetz","orcid":"https://orcid.org/0000-0002-4383-270X","observed_orcids":["https://orcid.org/0000-0002-4383-270X","https://orcid.org/0000-0003-3588-024X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew P. Goetz","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022511085","display_name":"Charles Erlichman","orcid":"https://orcid.org/0000-0002-1687-7080","observed_orcids":["https://orcid.org/0000-0002-1687-7080"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Erlichman","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113581453","display_name":"Anthony J. Windebank","orcid":"https://orcid.org/0000-0003-3481-0274","observed_orcids":["https://orcid.org/0000-0003-3481-0274"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony J. Windebank","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027416118","display_name":"Joel M. Reid","orcid":"https://orcid.org/0000-0003-2872-3123","observed_orcids":["https://orcid.org/0000-0003-2872-3123"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel M. Reid","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113667219","display_name":"Jeffrey A. Sloan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Sloan","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107094424","display_name":"Pamela J. Atherton","orcid":"https://orcid.org/0000-0002-8078-337X","observed_orcids":["https://orcid.org/0000-0002-8078-337X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela Atherton","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113962365","display_name":"Alex A. Adjei","orcid":"https://orcid.org/0000-0002-8039-6556","observed_orcids":["https://orcid.org/0000-0002-8039-6556"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex A. Adjei","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090904568","display_name":"Joseph Rubin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Rubin","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111498614","display_name":"Henry Clement Pitot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Henry Pitot","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017494786","display_name":"Evanthia Galanis","orcid":"https://orcid.org/0000-0001-8014-786X","observed_orcids":["https://orcid.org/0000-0001-8014-786X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evanthia Galanis","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066722006","display_name":"Matthew M. Ames","orcid":"https://orcid.org/0000-0003-3652-209X","observed_orcids":["https://orcid.org/0000-0003-3652-209X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew M. Ames","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080788977","display_name":"Richard M. Goldberg","orcid":"https://orcid.org/0000-0003-0308-8223","observed_orcids":["https://orcid.org/0000-0003-0308-8223","https://orcid.org/0000-0003-3713-6895"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Goldberg","raw_affiliation_strings":["From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":null,"apc_paid":null,"fwci":2.2422,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.87358802,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"21","issue":"20","first_page":"3761","last_page":"3769"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.8817999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.8817999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.07000000029802322,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9900000095367432},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.8529999852180481},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7570000290870667},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7300000190734863},{"id":"https://openalex.org/keywords/platinum-pharmacokinetics","display_name":"platinum pharmacokinetics","score":0.7099999785423279},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.906000018119812},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.5149999856948853},{"id":"https://openalex.org/keywords/schedule-comparison","display_name":"schedule comparison","score":0.5199999809265137},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6690000295639038},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6700000166893005},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.9210000038146973},{"id":"https://openalex.org/keywords/dose-de-escalation","display_name":"dose de-escalation","score":0.8539999723434448},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.36800000071525574},{"id":"https://openalex.org/keywords/folfox","display_name":"FOLFOX","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9243355989456177},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.9104812145233154},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7105661034584045},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6733940839767456},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.6267825365066528},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.5898211002349854},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.570742130279541},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.562967836856842},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.49525681138038635},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4806298613548279},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.45994776487350464},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.39813584089279175},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3356497883796692},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3318522572517395},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.16893982887268066},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14940106868743896}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2003.01.238","doi":"https://doi.org/10.1200/jco.2003.01.238","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2003.01.238","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:12963697","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12963697","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G5918705860","display_name":"General Clinical Research Center","funder_award_id":"M01RR000585","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G7378085456","display_name":"Phase I Clinical Trials of Anticancer Agents","funder_award_id":"U01CA069912","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G844520391","display_name":null,"funder_award_id":"CA 15083","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000866180","display_name":"Mayo Clinic Comprehensive Cancer Center Support Grant","funder_award_id":"P30CA015083","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G932523968","display_name":null,"funder_award_id":"CA 69912","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W63364447","https://openalex.org/W87107856","https://openalex.org/W181158363","https://openalex.org/W1502025781","https://openalex.org/W1521764325","https://openalex.org/W1549846058","https://openalex.org/W1577225521","https://openalex.org/W1794341310","https://openalex.org/W1835830368","https://openalex.org/W1847455118","https://openalex.org/W1885154202","https://openalex.org/W1897082568","https://openalex.org/W1897637667","https://openalex.org/W1929570960","https://openalex.org/W1941365207","https://openalex.org/W1952431753","https://openalex.org/W1967156508","https://openalex.org/W1971045589","https://openalex.org/W1976069289","https://openalex.org/W1981266251","https://openalex.org/W1985826300","https://openalex.org/W1991876073","https://openalex.org/W1996167718","https://openalex.org/W1996564028","https://openalex.org/W2006824814","https://openalex.org/W2012846370","https://openalex.org/W2015829835","https://openalex.org/W2031436799","https://openalex.org/W2033465919","https://openalex.org/W2037563824","https://openalex.org/W2059234543","https://openalex.org/W2066546242","https://openalex.org/W2069733373","https://openalex.org/W2091520513","https://openalex.org/W2096122707","https://openalex.org/W2098803991","https://openalex.org/W2100651878","https://openalex.org/W2110650955","https://openalex.org/W2117500868","https://openalex.org/W2118553080","https://openalex.org/W2123058403","https://openalex.org/W2128447158","https://openalex.org/W2128941960","https://openalex.org/W2132039541","https://openalex.org/W2139248078","https://openalex.org/W2141086589","https://openalex.org/W2142100270","https://openalex.org/W2150914452","https://openalex.org/W2152486489","https://openalex.org/W2157769714","https://openalex.org/W2162313061","https://openalex.org/W2169946736","https://openalex.org/W2170475716","https://openalex.org/W2227373247","https://openalex.org/W2253033732","https://openalex.org/W2274948752","https://openalex.org/W2285157229","https://openalex.org/W2294798321","https://openalex.org/W2314927739","https://openalex.org/W2398845930","https://openalex.org/W2400318368","https://openalex.org/W3092754547","https://openalex.org/W4243932715","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W1855714470","https://openalex.org/W2156942788","https://openalex.org/W1962270700","https://openalex.org/W2050644461","https://openalex.org/W2142476983","https://openalex.org/W2145139896","https://openalex.org/W2041240039","https://openalex.org/W2100651878","https://openalex.org/W2308212596","https://openalex.org/W2146798192"],"abstract_inverted_index":{"PURPOSE:":[0],"We":[1],"sought":[2],"to":[3,104,209],"determine":[4],"the":[5,11,36,129,142,178,183,205,218,237,240,260],"maximum-tolerated":[6],"dose":[7,85,120,144,146],"(MTD)":[8],"and":[9,13,24,54,62,64,70,97,123,153,164,231,252],"evaluate":[10],"toxicities":[12,202],"clinical":[14],"activity":[15,169],"of":[16,38,112,185,207],"two":[17],"irinotecan":[18],"(CPT-11),":[19],"fluorouracil":[20],"(FU),":[21],"leucovorin":[22],"(LV),":[23],"oxaliplatin":[25,41,65,208,225,246],"schedules":[26],"in":[27,138,172,189],"patients":[28,47,90,186],"with":[29,266],"advanced":[30],"solid":[31],"tumors.":[32],"Additionally,":[33],"we":[34],"investigated":[35],"effect":[37],"CPT-11":[39,52,222,243],"on":[40,57,67],"pharmacokinetics.":[42],"PATIENTS":[43],"AND":[44],"METHODS:":[45],"Thirteen":[46],"(cohort":[48],"1)":[49,96],"received":[50,91],"intravenous":[51,92],"(infusion)":[53,66],"FU/LV":[55,98],"(bolus)":[56],"days":[58,68,102],"1,":[59],"8,":[60],"15,":[61],"22":[63],"1":[69,149],"15":[71],"every":[72,106],"6":[73],"weeks":[74,108],"for":[75,109,217,236,262],"a":[76,110],"total":[77,111,179],"37":[78],"courses":[79,114],"(median,":[80,115],"three":[81,84,119],"courses)":[82,117],"at":[83,118,128,141],"levels.":[86,121],"Twenty-two":[87],"cohort":[88,130,156,176],"2":[89,103,131,191],"CPT-11/oxaliplatin":[93,267],"(infusion,":[94],"day":[95],"(90-minute":[99],"bolus":[100],"infusion,":[101],"5)":[105],"3":[107],"122":[113],"four":[116],"Pharmacokinetic":[122],"neurotoxicity":[124,196,265],"assessments":[125],"were":[126,166],"performed":[127],"MTD.":[132],"RESULTS:":[133],"Dose-limiting":[134],"toxicity":[135],"(DLT)":[136],"seen":[137,171],"both":[139,173],"cohorts":[140],"starting":[143],"required":[145],"de-escalation.":[147],"Cohort":[148],"DLT":[150],"included":[151],"diarrhea":[152],"neutropenia.":[154],"In":[155,175],"2,":[157,177],"diarrhea,":[158],"vomiting,":[159],"dehydration,":[160],"neutropenia,":[161,163],"febrile":[162],"paresthesias":[165],"DLTs.":[167],"Antitumor":[168],"was":[170,197],"cohorts.":[174],"platinum":[180,257],"area":[181],"under":[182],"curve":[184],"increased":[187],"17%":[188],"cycle":[190],"(P":[192],"=.048),":[193],"but":[194,213],"objective":[195],"not":[198],"seen.":[199],"CONCLUSION:":[200],"The":[201,215],"resulting":[203],"from":[204],"addition":[206],"CPT-11/FU/LV":[210],"are":[211,221,242],"significant":[212],"manageable.":[214],"MTDs":[216,241],"weekly":[219],"schedule":[220],"(75":[223],"mg/m2),":[224,227,230,245,248,251],"(50":[226],"FU":[228,249],"(320":[229],"LV":[232,253],"(20":[233,254],"mg/m2);":[234],"and,":[235],"3-weekly":[238],"schedule,":[239],"(175":[244],"(85":[247],"(240":[250],"mg/m2).":[255],"Second-cycle":[256],"accumulation":[258],"raises":[259],"possibility":[261],"enhanced":[263],"cumulative":[264],"combinations.":[268]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}